Patent World Magazine
Pfizer wins Lipitor patent case
Ireland
– A court in Ireland has ruled in favour of Pfizer and its patent for cholesterol drug Lipitor. The decision, which is subject
to appeal, prevents Ranbaxy from launching its version of the drug till November 2010 when the patent expires, as it would
infringe the basic patent covering atorvastin – the active ingredient in Liptior.